T. Rowe Price Associates’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$582K Buy
390,016
+77,989
+25% +$119K ﹤0.01% 2382
2025
Q4
$412K Buy
312,027
+23,189
+8% +$29.1K ﹤0.01% 2482
2025
Q3
$396K Sell
288,838
-209,607
-42% -$279K ﹤0.01% 2464
2025
Q2
$703K Buy
498,445
+65,038
+15% +$92.2K ﹤0.01% 2141
2025
Q1
$690K Sell
433,407
-3,507,628
-89% -$8.54M ﹤0.01% 2129
2024
Q4
$14M Sell
3,941,035
-3,095,583
-44% -$12.4M ﹤0.01% 1069
2024
Q3
$31.9M Sell
7,036,618
-4,241,305
-38% -$19.3M ﹤0.01% 874
2024
Q2
$47.8M Buy
11,277,923
+9,212,960
+446% +$35.9M 0.01% 738
2024
Q1
$6.82M Buy
2,064,963
+1,877,184
+1,000% +$4.21M ﹤0.01% 1166
2023
Q4
$397K Buy
187,779
+16,501
+10% +$32.1K ﹤0.01% 2273
2023
Q3
$364K Sell
171,278
-63,855
-27% -$173K ﹤0.01% 2262
2023
Q2
$755K Buy
235,133
+79,322
+51% +$226K ﹤0.01% 1942
2023
Q1
$339K Sell
155,811
-44,766
-22% -$127K ﹤0.01% 2287
2022
Q4
$485K Sell
200,577
-2,713
-1% -$6.08K ﹤0.01% 2144
2022
Q3
$476K Buy
203,290
+22,009
+12% +$49.3K ﹤0.01% 2153
2022
Q2
$281K Buy
181,281
+6,941
+4% +$9.81K ﹤0.01% 2473
2022
Q1
$237K Buy
174,340
+7,367
+4% +$8.21K ﹤0.01% 2651
2021
Q4
$204K Sell
166,973
-5,600
-3% -$8.02K ﹤0.01% 2750
2021
Q3
$236K Buy
172,573
+2,843
+2% +$3.79K ﹤0.01% 2660
2021
Q2
$239K Buy
169,730
+3,555
+2% +$5.17K ﹤0.01% 2661
2021
Q1
$263K Sell
166,175
-29,282
-15% -$52.3K ﹤0.01% 2606
2020
Q4
$311K Buy
195,457
+643
+0.3% +$1.17K ﹤0.01% 2415
2020
Q3
$339K Buy
194,814
+27,917
+17% +$51.6K ﹤0.01% 2245
2020
Q2
$364K Sell
166,897
-75,299
-31% -$113K ﹤0.01% 2182
2020
Q1
$288K Buy
242,196
+58,800
+32% +$72K ﹤0.01% 2200
2019
Q4
$249K Buy
183,396
+7,598
+4% +$11K ﹤0.01% 2367
2019
Q3
$234K Buy
175,798
+940
+0.5% +$1.26K ﹤0.01% 2363
2019
Q2
$247K Buy
174,858
+400
+0.2% +$661 ﹤0.01% 2360
2019
Q1
$290K Buy
174,458
+500
+0.3% +$683 ﹤0.01% 2306
2018
Q4
$174K Buy
173,958
+90,021
+107% +$137K ﹤0.01% 2434
2018
Q3
$148K Sell
83,937
-2,169
-3% -$9.46K ﹤0.01% 2500
2018
Q2
$295K Buy
86,106
+216
+0.3% +$825 ﹤0.01% 2349
2018
Q1
$365K Buy
85,890
+66,690
+347% +$180K ﹤0.01% 2204
2017
Q4
$35K Sell
19,200
-90,200
-82% -$182K ﹤0.01% 2552
2017
Q3
$238K Hold
109,400
﹤0.01% 2351
2017
Q2
$303K Sell
109,400
-13,100
-11% -$34.8K ﹤0.01% 2242
2017
Q1
$278K Hold
122,500
﹤0.01% 2289
2016
Q4
$254K Hold
122,500
﹤0.01% 2306
2016
Q3
$277K Hold
122,500
﹤0.01% 2250
2016
Q2
$328K Sell
122,500
-39,200
-24% -$114K ﹤0.01% 2126
2016
Q1
$472K Buy
161,700
+71,900
+80% +$215K ﹤0.01% 1996
2015
Q4
$435K Buy
89,800
+400
+0.4% +$1.61K ﹤0.01% 2016
2015
Q3
$247K Hold
89,400
﹤0.01% 2212
2015
Q2
$383K Buy
89,400
+29,500
+49% +$117K ﹤0.01% 2109
2015
Q1
$226K Sell
59,900
-18,200
-23% -$61.8K ﹤0.01% 2315
2014
Q4
$254K Sell
78,100
-52,800
-40% -$146K ﹤0.01% 2252
2014
Q3
$262K Buy
130,900
+55,041
+73% +$136K ﹤0.01% 2209
2014
Q2
$230K Buy
75,859
+26,345
+53% +$55K ﹤0.01% 2300
2014
Q1
$97K Hold
49,514
﹤0.01% 2431
2013
Q4
$222K Buy
49,514
+21,160
+75% +$90.8K ﹤0.01% 2278
2013
Q3
$90K Hold
28,354
﹤0.01% 2397
2013
Q2
$40K Buy
+28,354
New +$30.8K ﹤0.01% 2408

Other funds holding GERN

T. Rowe Price Associates's GERN Position: Q1 2026 in Review

T. Rowe Price Associates increased its Geron (GERN) stake by 25% in Q1 2026, buying an estimated $119K and bringing the position to 390,016 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

T. Rowe Price Associates first reported a position in GERN in Q2 2013 and has held it in 52 quarters since. The position peaked at $47.8M in Q2 2024. 256 funds tracked by Wall St. Rank hold GERN as of Q1 2026.

  • T. Rowe Price Associates held 390,016 shares of Geron worth $582K as of Q1 2026.
  • T. Rowe Price Associates bought 77,989 Geron shares in Q1 2026, an estimated $119K.
  • Geron made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2382 holding.
  • T. Rowe Price Associates first reported a position in Geron in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Geron position peaked at $47.8M in Q2 2024.
  • 256 funds tracked by Wall St. Rank held Geron as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.